Endo Shareholders Fight Bid To Nix Generic Price-Fixing Suit
A proposed class of Endo Pharmaceuticals shareholders has asked a Pennsylvania federal judge to reject the company's bid to dismiss a suit claiming the drugmaker inflated stock prices by concealing a...To view the full article, register now.
Already a subscriber? Click here to view full article